HomeAI · summaries
Storia in 12 fonti
White House denies Trump was mystery patient given early access to weight-loss drug
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWhite House officials are denying that President Donald Trump was the 79-year-old patient who reportedly received early access to retatrutide, an experimental weight loss drug, under "compassionate use." Health news site STAT reported that drug maker Eli Lilly and the FDA granted a 79-year-old patient access to the treatment for severe health complications, including refractory obesity, obstructive sleep apnea and pulmonary hypertension. White House spokesman Kush Desai called suggestions that Trump was the patient "baseless speculation," and other White House accounts accused commentators of spreading "bulls***." The patient's request for the drug reportedly drew interest from top health officials, suggesting they were "well connected." Trump, who is now 80, previously received early access to an antibody therapy for Covid during the pandemic and has denied using weight loss drugs like Wegovy and Ozempic. In fullWhite House denies Trump is the ‘well-connected’ man who gained compassionate access to obesity drug in AprilThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
newrepublic.com
Remember That Time Trump Said He “Probably Should” Take Ozempic?
A bombshell report about how a 79-year-old man got early access to a weight loss drug has all eyes on the president.
- ·
forbes.com
White House Denies Trump Was Given Exclusive Weight Loss Drug
A report from STAT News said Eli Lilly and the FDA gave a 79-year-old man exclusive access to the drug after a request for it was made in April.
- ·
Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient
Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented access to a weight-loss drug.
- ·
White House Flips Out Over Report Trump May Be on Weight Loss Drug
A stunning report reveals the president may have gotten an early access to an obesity drug to treat major medical issues.
- ·
medpagetoday.com
White House Denies Trump Got Unapproved Obesity Drug
Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension
- ·
arstechnica.com
Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
Public notice of a single "compassionate use" case is odd in every way.
- ·
huffpost.com
It Kinda Looks Like Trump Might Be Taking An Experimental Obesity Drug?
Retatrutide has not been approved by the FDA, but precisely one 79-year-old man was granted access via "compassionate use."
- ·
slate.com
Is Donald Trump Sick? A Bombshell New Scoop May Provide Our First Real Clue.
A new report raises some questions the president would surely rather not answer.
- ·
gizmodo.com
Just Who Is the Mystery 79-Year-Old Patient Who Got Special Access to an Experimental Weight Loss Drug?
The White House has denied that the application was filed on behalf of President Donald Trump.
- ·
independent.co.uk
White House denies Trump is the mystery patient who got early access to obesity drug
A White House spokesman said theories that President Trump sought the drug were ‘baseless speculation’
- ·
nymag.com
Did Trump Get Early Access to Eli Lilly’s New Weight-Loss Drug?
The FDA let one 79-year-old take an experimental obesity drug. That sure sounds like the president, but let’s examine the evidence.
- ·
Is Donald Trump on a Wonder Weight Loss Drug? Here’s What You Need to Know.
Let us answer your questions about a slightly serious—but deeply amusing—medical mystery.
- ·
Is Trump on an Experimental Weight Loss Drug? An Investigation.
The FDA gave one well-connected 79-year-old early access to Eli Lilly’s new drug. Its sure sounds like the president, but let’s examine the evidence.
- ·
White House denies Trump was mystery patient given early access to weight-loss drug
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWhite House officials are denying that…
- ·
washingtonexaminer.com
White House denies report Trump got access to experimental weight loss drug
The White House denied that the single approval of Eli Lilly's highly-anticipated weight loss drug retatrutide was for Trump after a STAT report.
- ·
benzinga.com
White House Denies Report Linking Trump To Eli Lilly's Experimental Obesity Treatment: 'Not For The Presi
White House denies reports Trump received Eli Lilly's unapproved obesity drug retatrutide through an FDA program.
- ·
hindustantimes.com
Is Trump getting Eli Lilly's retatrutide? ‘Breathless’ clip viral amid debunked ‘compassionate use’ rumor
Trump faced fresh health speculation after reports linked him to an experimental drug and a viral video, but the White House denied the medication claim.